Pular para o conteúdo principal
Ranking Invest

HROW - Harrow Health, Inc.

Segmento: HealthcareHarrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Análise Ranking Invest

Valuation estimado
-9,88%
-$ 66.37 Mi
Valor de Mercado
$ 1.29 Bi
Desconto (AV)-2048.0%
IVR
-0.05A companhia vale -0,05 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.07O valuation alternativo equivale a -7% do valor de mercado da companhia.
MLL
-0.07O lucro líquido dos controladores em 16 trimestres equivale a -7% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 15.55 Mi

Dívida Líquida

-$ 83.89 Mi

L4T

-$ 37.23 Mi

MM4T

-19.51%

Indicadores Básicos

ROE

-239.32%

Índices de Previsibilidade

Receita Líquida

D0.13

Lucro

E1.07

Margem

D1.00

Índices de Tendência

Receita Líquida

B10.13

Lucro

E-2.27

Margem

D-0.40

Índices de Endividamento

DIV/PAT

-5.39

DIV/L4T

2.25

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.